Jacobio Pharmaceuticals Group Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-168.00
-396.00
-432.00
-362.00
-1,700.00
-482.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
83.00
-14.00
153.00
130.00
-180.00
3.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-42.00
-380.00
-342.00
-177.00
87.00
-125.00
Cash Flow from Investing Activities
232.00
-89.00
-792.00
205.00
-247.00
-14.00
Cash Flow from Financing Activities
30.00
275.00
-8.00
132.00
1,441.00
12.00
Net Cash Inflow / Outflow
225.00
-183.00
-1,044.00
127.00
1,255.00
-120.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
11.00
99.00
-31.00
-25.00
6.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jacobio Pharmaceuticals Group Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-168.823410292521
25.0806874713922
-193.00
-773.12%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
83.5654684371859
-178.091751753535
261.00
146.92%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-42.2142553079101
36.167769890316
-78.00
-216.72%
Cash Flow from Investing Activities
232.523729487341
395.638463734055
-163.00
-41.23%
Cash Flow from Financing Activities
30.2053920283307
-782.70919283938
812.00
103.86%
Net Cash Inflow / Outflow
225.450253138842
-364.981157090393
589.00
161.77%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.93538693108013
-14.0781978753845
18.00
135.06%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 88.92% vs -11.14% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-42.21
-380.85
88.92%






